References
- Monu JU, Pope TL. Gout: a clinical and radiologic review. Radiologic Clinics. 2004;42(1):169–184.
- Liu S, Perez-Ruiz F, Miner JN. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid. Joint Bone Spine. 2017;84(2):183–188.
- Lee YM, Son E, Kim D-S. Comparative study of anti-gouty arthritis effects of sam-myo-whan according to extraction solvents. Plants. 2021;10(2):278.
- Carmichael LP. Treatment of acute gout with injection of colchicine. J Am Med Assoc. 1959;170(12):1410–1411.
- Abbott CE, Xu R, Sigal SH. Colchicine-induced hepatotoxicity. ACG Case Rep J. 2017;4(1):e120.
- Wason S, Mount D, Faulkner R. Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease. Clin Drug Invest. 2014;34(12):845–855.
- Hung I, Wu A, Cheng V, et al. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis. 2005;41(3):291–300.
- Reddy LH, Sharma R, Chuttani K, et al. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. J Controlled Release. 2005;105(3):185–198.
- Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Delivery Rev. 2006;58(2):226–242.
- Allen KD, Adams SB, Jr, Setton LA. Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model. Tissue Eng Part B Rev. 2010;16(1):81–92.
- Mello SB, Tavares ER, Bulgarelli A, et al. Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis. Int J Nanomed. 2013;(8): 443–449.
- Sutradhar KB, Amin ML. Nanoemulsions: increasing possibilities in drug delivery. Eur J Nanomed. 2013;5(2):97–110.
- Devarajan V, Ravichandran V. Nanoemulsions: as modified drug delivery tool. Int J Compr Pharm. 2011;2(4):1–6.
- Chandra A, Sharma P, Irchhiaya R. Microemulsion-based hydrogel formulation for transdermal delivery of dexamethasone. Asian J Pharm. 2009;3(1):30–36.
- Rasal A, Mahajan H, Shaikh H, et al. Development and characterization of nasal mucoadhesive microemulsion of sumatriptan succinate. Indian J Novel Drug Deliv. 2010;2:103–108.
- Bagley D, Gardner J, Holland G, et al. Skin irritation: reference chemicals data bank. Toxicol in Vitro. 1996;10(1):1–6.
- Geskovski N, Kuzmanovska S, Simonoska Crcarevska M, et al. Comparative biodistribution studies of technetium‐99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure. J Labelled Compd Radiopharm. 2013;56(14):689–695.
- Ibrahim I, El-Kolaly M, Aboumanei M, et al. 125I labeling of clomiphene and biodistribution studies for possible use as a model in breast cancer imaging. Appl Radiat Isot. 2016;115:37–44.
- Motaleb H, Ibrahim IT, El‐Tawoosy M, et al. Synthesis, preclinical, and pharmacokinetic evaluation of a new zoledronate derivative as a promising antiosteoporotic candidate using radiolabeling technique. J Labelled Compd Radiopharm. 2017;60(11):542–549.
- Lee H-S, Lee C-H, Tsai H-C, et al. Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1β. Osteoarthr Cartil. 2009;17(1):91–99.
- Zhou Q, Lin FF, Liu SM, et al. Influence of the total saponin fraction from Dioscorea nipponica Makino on TLR2/4-IL1R receptor singnal pathway in rats of gouty arthritis. J Ethnopharmacol. 2017;206:274–282.
- Mariotte A, De Cauwer A, Po C, et al. A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients. Theranostics. 2020;10(5):2158.
- Hohlbaum K, Bert B, Dietze S, et al. Impact of repeated anesthesia with ketamine and xylazine on the well-being of C57BL/6JRj mice. PLoS One. 2018;13(9):e0203559.
- Aboumanei MH, Mahmoud AF. Design and development of a proniosomal transdermal drug delivery system of caffeine for management of migraine: In vitro characterization, 131I-radiolabeling and in vivo biodistribution studies. Process Biochem. 2020;97:201–212.
- Aboumanei MH, Mahmoud AF, Motaleb M. Formulation of chitosan coated nanoliposomes for the oral delivery of colistin sulfate: in vitro characterization, 99mTc-radiolabeling and in vivo biodistribution studies. Drug Dev Ind Pharm. 2021;47(4):626–610.
- Mehta S, Kaur G, Bhasin K. Tween-embedded microemulsions—physicochemical and spectroscopic analysis for antitubercular drugs. AAPS PharmSciTech. 2010;11(1):143–153.
- Resende KX, Corrêa MA, Oliveira AGd, et al. Effect of cosurfactant on the supramolecular structure and physicochemical properties of non-ionic biocompatible microemulsions. Rev Bras Cienc Farm. 2008;44(1):35–42.
- Kawakami K, Yoshikawa T, Moroto Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. J Controlled Release. 2002;81(1-2):65–74.
- Kale NJ, Allen LV. Studies on microemulsions using Brij 96 as surfactant and glycerin, ethylene glycol and propylene glycol as cosurfactants. Int J Pharm. 1989;57(2):87–93.
- Tayel SA, El-Nabarawi MA, Tadros MI, et al. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 2013;443(1-2):293–305. Feb 25
- Xi J, Chang Q, Chan CK, et al. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid [Comparative Study Evaluation Studies Research Support, Non-U.S. Gov't]. AAPS PharmSciTech. 2009;10(1):172–182.
- Aboumanei MH, Abdelbary AA, Ibrahim IT, et al. Design and development of microemulsion systems of a new antineoplaston A10 analog for enhanced intravenous antitumor activity: In vitro characterization, molecular docking, 125I-radiolabeling and in vivo biodistribution studies. Int J Pharm. 2018;545(1-2):240–253.
- Masarudin MJ, Cutts SM, Evison BJ, et al. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnol Sci Appl. 2015;8:67–80.
- Müller R, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47(1):3–19.
- De Lima LS, Araujo MDM, Quináia SP, et al. Adsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial design. Chem Eng J. 2011;166(3):881–889.
- Ibrahim N, Ab Raman I, Yusop MR. Effects of functional group of non-ionic surfactants on the stability of emulsion. Malaysian J Anal Sci. 2015;19(1):261–267.
- Gupta M, Vaidya B, Mishra N, et al. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Biotechnol. 2011;39(6):376–384.
- Harun SN, Nordin SA, Abd Gani SS, et al. Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: Designs, characterizations, and pharmacokinetics. Int J Nanomed. 2018;13:2571.
- Wu Z, Alany RG, Tawfeek N, et al. A study of microemulsions as prolonged-release injectables through in-situ phase transition. J Controlled Release. 2014;174:188–194.
- Leung YY, Hui LLY, Kraus VB. Colchicine—Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015;45(3):341–350.